European NeuroEndocrine Tumours Society (ENETS) Lyon Center of Excellence, Lyon, France
Search for other papers by Laura Gerard in
Google Scholar
PubMed
Search for other papers by David Barthelemy in
Google Scholar
PubMed
Search for other papers by Arnaud Gauthier in
Google Scholar
PubMed
Institut Multi-Site de Pathologie et Biologie Moléculaire, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron, France
Université de Lyon, Université Claude Bernard Lyon 1, Villeurbanne Cedex, France
Search for other papers by Valerie Hervieu in
Google Scholar
PubMed
Institut Multi-Site de Pathologie et Biologie Moléculaire, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron, France
Université de Lyon, Université Claude Bernard Lyon 1, Villeurbanne Cedex, France
Search for other papers by Jonathan Lopez in
Google Scholar
PubMed
Search for other papers by Benjamin Gibert in
Google Scholar
PubMed
Université de Lyon, Université Claude Bernard Lyon 1, Villeurbanne Cedex, France
Fédération d’Endocrinologie, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron Cedex, France
Search for other papers by Helene Lasolle in
Google Scholar
PubMed
Search for other papers by Laurence Chardon in
Google Scholar
PubMed
Search for other papers by Jessica Garcia in
Google Scholar
PubMed
Université de Lyon, Université Claude Bernard Lyon 1, Villeurbanne Cedex, France
INSERM, UMR 1052, Lyon Cancer Research Center, Faculté Laennec, Lyon Cedex 08, France
Fédération d’Endocrinologie, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron Cedex, France
Search for other papers by Gérald Raverot in
Google Scholar
PubMed
Université de Lyon, Université Claude Bernard Lyon 1, Villeurbanne Cedex, France
Search for other papers by Léa Payen in
Google Scholar
PubMed
European NeuroEndocrine Tumours Society (ENETS) Lyon Center of Excellence, Lyon, France
Université de Lyon, Université Claude Bernard Lyon 1, Villeurbanne Cedex, France
INSERM, UMR 1052, Lyon Cancer Research Center, Faculté Laennec, Lyon Cedex 08, France
Search for other papers by Thomas Walter in
Google Scholar
PubMed
Background Neuroendocrine carcinomas (NEC) are associated with paraneoplastic syndrome, such as Cushing’s syndrome, in less than 5% of cases. NEC are usually treated with first-line platinum-etoposide chemotherapy and then with FOLFOX, FOLFIRI
Search for other papers by Stéphanie Larose in
Google Scholar
PubMed
Search for other papers by Dany Rioux in
Google Scholar
PubMed
Search for other papers by Roula Albadine in
Google Scholar
PubMed
Search for other papers by André Lacroix in
Google Scholar
PubMed
Learning points Large-cell neuroendocrine carcinoma (LCNEC) of the lung is a rare cause of ectopic adrenocorticotrophic hormone secretion (EAS) causing paraneoplastic Cushing’s syndrome. Desmopressin, CRH or dexamethasone suppression
St Vincent’s Hospital Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, Australia
Garvan Institute of Medical Research, Sydney, Australia
Search for other papers by Anna Stroud in
Google Scholar
PubMed
St Vincent’s Hospital Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, Australia
Garvan Institute of Medical Research, Sydney, Australia
Search for other papers by Pearl Dhaliwal in
Google Scholar
PubMed
Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia
Search for other papers by Richard J Harvey in
Google Scholar
PubMed
Search for other papers by Raquel Alvarado in
Google Scholar
PubMed
Faculty of Medicine, Notre Dame University, Sydney, Australia
Institute of Academic Surgery, Royal Prince Alfred Hospital, Sydney, Australia
Search for other papers by Benjamin P Jonker in
Google Scholar
PubMed
St Vincent’s Hospital Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, Australia
Faculty of Medicine, Notre Dame University, Sydney, Australia
Search for other papers by Mark J Winder in
Google Scholar
PubMed
Department of Otolaryngology Head and Neck Surgery, University of Alabama Birmingham, Birmingham, Alabama, USA
Search for other papers by Jessica W Grayson in
Google Scholar
PubMed
Garvan Institute of Medical Research, Sydney, Australia
Department of Endocrinology, St Vincent’s Hospital, Sydney, Australia
Search for other papers by Ann McCormack in
Google Scholar
PubMed
://doi.org/10.1210/jc.2011-2957 ) 10.1210/jc.2011-2957 Invitti C Pecori Giraldi F De Martin M Cavagnini F 1999 Diagnosis and management of Cushing’s syndrome: results of an Italian multicentre study . Journal of Clinical Endocrinology and Metabolism
Search for other papers by Nadia Gagnon in
Google Scholar
PubMed
Lipids, Nutrition and Cardiovascular Prevention Clinic of the Montreal Clinical Research Institute, Montreal, Québec, Canada
Search for other papers by Sophie Bernard in
Google Scholar
PubMed
Search for other papers by Martine Paquette in
Google Scholar
PubMed
Search for other papers by Catherine Alguire in
Google Scholar
PubMed
Search for other papers by André Lacroix in
Google Scholar
PubMed
Search for other papers by Pierre-Olivier Hétu in
Google Scholar
PubMed
Search for other papers by Harold J Olney in
Google Scholar
PubMed
Search for other papers by Isabelle Bourdeau in
Google Scholar
PubMed
Endocrinology 179 G1– G46 . ( https://doi.org/10.1530/EJE-18-0608 ) Greenman Y 2010 Management of dyslipidemia in Cushing’s syndrome . Neuroendocrinology 92 ( Supplement 1 ) 91 – 95 . ( https://doi.org/10.1159/000314294 ) 10.1159/000314294 Hescot S
Search for other papers by Sara Coelho in
Google Scholar
PubMed
Search for other papers by Cláudia Costa in
Google Scholar
PubMed
Research Center, Portuguese Oncology Institute of Porto, EPE, Porto, Portugal
Search for other papers by Ana Paula Santos in
Google Scholar
PubMed
Search for other papers by Pedro Souteiro in
Google Scholar
PubMed
Search for other papers by Joana Oliveira in
Google Scholar
PubMed
Search for other papers by Júlio Oliveira in
Google Scholar
PubMed
Search for other papers by Isabel Azevedo in
Google Scholar
PubMed
Search for other papers by Isabel Torres in
Google Scholar
PubMed
School of Medicine and Biomedical Sciences, University of Porto, Porto, Portugal
Search for other papers by Maria José Bento in
Google Scholar
PubMed
-related Cushing’s syndrome. In our study, we found a higher proportion of arterial hypertension and diabetes mellitus in NET grade 2 and of current or past history of non-neuroendocrine malignancy in NET grade 1. At diagnosis, tumor and hormone secretion
Search for other papers by Eleanor Fewings in
Google Scholar
PubMed
Search for other papers by Serena Khoo Sert Kim in
Google Scholar
PubMed
Search for other papers by Alexey Larionov in
Google Scholar
PubMed
Search for other papers by Alison Marker in
Google Scholar
PubMed
Search for other papers by Olivier Giger in
Google Scholar
PubMed
Search for other papers by Ashley Shaw in
Google Scholar
PubMed
Search for other papers by Graeme R Clark in
Google Scholar
PubMed
Search for other papers by Vasilis Kosmoliaptsis in
Google Scholar
PubMed
Search for other papers by Benjamin G Challis in
Google Scholar
PubMed
East Anglian Medical Genetics Service, Cambridge University Hospital NHS Foundation Trust, Cambridge, UK
Search for other papers by Marc Tischkowitz in
Google Scholar
PubMed
Department of Endocrinology, Cambridge University Hospital NHS Foundation Trust, Cambridge, UK
Search for other papers by Ruth T Casey in
Google Scholar
PubMed
64 Sex M M F M M M M F F F Presenting feature Incidental Abdominal mass Incidental Incidental Cushing’s syndrome, hypogonadism Hypokalemia and proximal myopathy Incidental Incidental Incidental